In 2008 she was a visiting researcher at the Institute Galien Paris-Sud, in the group led by Prof. Her PhD thesis was focused on developing novel supercritical fluid technologies for preparing functional organic nanomaterials for biomedical applications. She worked on the development of emergency plans in industrial plants.Īwarded a 4-year FPU fellowship in 2004, she began her doctoral studies at the Materials Science Institute of Barcelona (ICMAB), under the guidance of Dr. José Ruiz Gimeno at the University of Murcia. From 2002 to 2003, she was a fellow in the research group of Industrial Hygiene and Safety led by Prof.
in Chemical Engineering from the University of Murcia in 2002.
Antonia María Cano Sarabia received her B.Sc. He has also filed eight patents and established 14 contracts with private companies, including two patent licence agreements and three successful transfers of in-house technology for immediate application in consumer products.ĭr. Maspoch has authored 97 scientific publications and five book chapters. In 2014 he was awarded an ERC Consolidator Grant. He has been an ICREA Research Professor and group leader at the ICN2 since September 2011. He moved back to the then ICN thanks to a Ramón y Cajal contract, where he founded the ICN2 Supramolecular Nanochemistry and Materials Group. He has authored over 115 papers and five book chapters. In 2015 he received the Marcial Moreno Mañas Lectureship award. Maspoch was awarded a prestigious ERC Consolidator Grant for the InanoMOF project to develop frontier methodologies for the synthesis of nanocomposites made from MOFs. He has been an ICREA research professor and group leader at the ICN2 since September 2011. He then spent two years at Northwestern University (USA) as a postdoctoral fellow in the group led by Prof. He is now the CEO of Ahead Therapeutics.ĭaniel's scientific career began with a degree in chemistry at the Universitat de Girona, followed by a PhD in materials science from the Universitat Autònoma de Barcelona and the Institut de Ciència de Materials de Barcelona. These include SOM Biotech (a drug repurposing company) TR Composites (carbon fiber components for aeronautics) Confirmsign (digital logistics provider) Nanosel (nanotech platform for cancer treatment) IDP Discovery Pharma (drug development to fight cancer) and Centauri Biotech (veterinary stem cell company). He was Healthcare Director at KIM (Knowledge Innovation Market), and he has founded some start-up companies, or helped them to grow, participating as a business angel (BA investor and in some cases as a member of the Board). In recent years, Marti has been very active in the technology transfer field. Marti has had responsibilities in different environments of the health sector: hospital management university lecturing consultancy at national and international level R&D+i project management science divulgation as a founder of "Educación Médica" scientific review. Pompeu Fabra (UPF) Master’s in Hyperbaric Medicine at Univ. Autònoma de Barcelona (UAB) Master’s in business administration (UAB) Master’s in Scientific Communication at Univ. She had a best doubles ranking of 213 and won seven doubles titles on the ITF Women's Circuit.PhD in Medicine - Univ. Her only WTA Tour main draw appearance came in doubles, at the 1997 Madrid Open.
#Marta cano de rodriguez professional#
Marta Cano (born 27 September 1975) is a Spanish former professional tennis player.Ĭano competed on the professional tour in the 1990s and reached a career high singles ranking of 356 in the world. Spanish tennis player Marta Cano Country (sports)
0 kommentar(er)
